Navigation Links
Clinical Launch of Innovative Cloth Sleep Apnea Mask Creates Buzz at Sleep Conference
Date:6/30/2008

PITTSBURGH, June 30 /PRNewswire/ -- Circadiance launched the revolutionary SleepWeaver(TM) Nasal CPAP Mask at the tradeshow of the 22nd Annual Meeting of the Associated Professional Sleep Societies, SLEEP 2008, which was held in Baltimore June 9 - 12.

Many sleep apnea patients discontinue their CPAP therapy because their CPAP mask causes discomfort, irritation and sleep interruption. The innovative SleepWeaver is the only 100 percent cloth CPAP mask on the market today. It gently inflates and softly conforms to the patient's face to create a seal, and because the cloth is flexible and follows the exact shape of each individual patient's face, air leakage is reduced. It is also designed to reduce mask noise to provide a good nights sleep. And unlike other masks, SleepWeaver has no plastic or silicone parts that touch the face, preventing it from irritating sensitive skin.

"There are several advantages of this method over conventional CPAP masks," explains David Groll, President of Circadiance. "The air pressure causes the soft, breathable cloth to balloon and conform easily to the patient's facial anatomy, creating the seal. There is no need for excess tension in the straps and no localized pressure points that can create pressure sores."

More than 5,000 scientists and doctors were in attendance at the conference. The SleepWeaver received an overwhelmingly favorable response from doctors, therapists and others in the sleep products industry.

Dr. Natalio Chediak MD, of the Boca Raton Sleep Center, who was introduced to the mask at this conference, commented, "This is the most unique interface at this meeting. I have never seen anything quite like it before. I can see its place in my practice. This is very impressive."

Another perspective came from sleep technician Joshua Whitaker, RPSGT of the Lake Point Sleep Lab in Rockwall TX: "This is awesome. The fact that the air pressure makes a cloth balloon is really awesome."


'/>"/>

SOURCE Circadiance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New clinical trial for patients with asbestos-associated lung cancer
2. Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy
3. Impliant Restarts European Clinical Activities for Patented TOPS(TM) Spine System
4. AUDIO from Medialink, Eli Lilly and the American Association of Clinical Endocrinologists: Dont let Natural Disasters Leave you Without Needed Medications
5. RF Technologies(R) Introduces Enhanced Clinical Support Service, Step-by-Step, a Comprehensive Program Designed to Ensure Infant Security
6. Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators
7. Evalve MitraClip: Clinical trial of nonsurgical repair for severe mitral valve regurgitation
8. Effective Communication of Clinical Studies for Maximum Impact
9. Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies
10. INACSL and Elsevier partner to publish Clinical Simulation in Nursing
11. Winning Method - Effective Identification and Development of Clinical Investigators
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 2Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 3Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 4Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 5Health News:Dr. Gunther von Hagens 'HUMAN SAGA' Project Presents Sexuality and Reproduction in New Exhibit, The Cycle of Life. 2Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 2Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 3Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 4Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 5Health News:VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter 6Health News:Probiotics may be able to help you keep fit and slim 2Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 2Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 3Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 4Health News:Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation 2Health News:Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation 3
Breaking Medicine Technology:Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Stevens team wins First Place in ISPE Student Poster Competition 10962 1New AERIUS Cell Phones Direct Microwave Signals Away from Users 62464 1New AERIUS Cell Phones Direct Microwave Signals Away from Users 62464 2Dr Alan F Dowling Named AHIMAs Next Chief Executive Officer 62460 1Dr Alan F Dowling Named AHIMAs Next Chief Executive Officer 62460 2